Neurology

Ceribell raises USD 35 Million in series B round Ceribell, Emergency EEG maker raised USD 35 million for commercializing its EEG system that can rapidly diagnose patients, who are supposed of not having convulsive seizures with no visual symptoms for the use in neurological intensive care units and emergency rooms. The Mountain View received 510(k) clearance from the FDA in 2017, is intended to identify patients within six minutes, compared to typical EEGs, which may take hours or days. Lyra reels USD 29.5Million to move chronic sinusitis drug into phase 2 Lyra Therapeutics is working for improving treatments of ear, nose and throat (ENT) diseases. The company has ba...